
Intraperitoneal antibiotic utilization among continuous ambulatory peritoneal dialysis (CAPD) patients with peritonitis at a tertiary hospital setting in Malaysia
Author(s) -
Mastura Ahmad,
Che Suraya Zin,
Ab Fatah Ab Rahman
Publication year - 2020
Publication title -
journal of pharmacy and bioallied sciences
Language(s) - English
Resource type - Journals
eISSN - 0976-4879
pISSN - 0975-7406
DOI - 10.4103/jpbs.jpbs_298_19
Subject(s) - medicine , cefazolin , peritonitis , continuous ambulatory peritoneal dialysis , ceftazidime , peritoneal dialysis , meropenem , vancomycin , amikacin , antibiotics , cefepime , pseudomonas aeruginosa , antibiotic resistance , staphylococcus aureus , genetics , bacteria , microbiology and biotechnology , biology
Patients receiving continuous ambulatory peritoneal dialysis (CAPD) are commonly associated with peritonitis. However, little is known about the utilization of antibiotics for the treatment of peritonitis in these patients.